Source: Eur Respir J 2006; 28: 35-44
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Diel R., Nienhaus A., Lange C., Schaberg T.. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J 2006; 28: 35-44

Member's Comments

No comment yet.

Related content which might interest you: Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 1285 Year: 2006 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Screening for latent tuberculosis in health care workers at low, moderate and high risk for tuberculosis exposure: a cost-effectiveness analysis Source: Annual Congress 2003 - Control of tuberculosis Year: 2003 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017 Indeterminate test results of T-SPOTTM.TB performed under routine field conditions Source: Eur Respir J 2008; 31: 842-846 Year: 2008 Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 New immunologic tools for the diagnosis and therapy of tuberculosis Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Significance of close contacts examination and chemoprophylaxis for epidemiologic control of tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 18s Year: 2006 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014